| | | |  | | | | By Adam Feuerstein The antibody treatment, which delivers targeted chemotherapy directly to cancer cells, caused tumors to disappear in some patients. Read More | | By Megan Molteni Adobe The Phase 1 trial found that the personally formulated gene-edited immune cells didn’t cure patients, but they didn’t kill anyone either. Read More | | By Adam Feuerstein Spencer Platt/Getty Images Shares of Merrimack, a shuttered drug company, more than doubled due to the success of a treatment for pancreatic cancer it once owned. Read More | | Sponsored Insight by The University of Texas MD Anderson Cancer Center The next wave of cancer breakthroughs is happening in Houston From investigators decoding the tumor microenvironment to physicians leading practice-changing trials, MD Anderson's research is driven by a singular goal to end cancer. Its physicians and scientists work seamlessly across disciplines to move new findings from the lab to the clinic and back. This cycle of innovation allows MD Anderson to rapidly bring discoveries to patients in need. Learn more about opportunities to join this passionate community driving the next wave of cancer breakthroughs. Find out about open positions here. | | By Adam Feuerstein Adobe Based on its current operating plan, Clovis does not have the financial resources to remain financially solvent beyond January 2023. Read More | | By Jessica Bartlett — Boston Globe Courtesy Barrett Rollins Oncologist Jane Weeks wanted to her breast cancer a secret. Her husband's new memoir, "In Sickness," is an attempt to understand why. Read More | | By Matthew Herper Adobe The company's announcement stands in stark contrast to the approach it indicated it would take three years ago. Read More | |
No comments